EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-Metaanalyse

Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis

Mengxia Yan, Ying Chen, Wen Li, Yun Bao, Kaijie Yao, Bin Wu

AME Medical Journal · 2026-06 · 11 · 15-15

DOI: 10.21037/amj-2026-0041 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift AME Medical Journal, 2026-06. Verfasst von Mengxia Yan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yan, M., Chen, Y., Li, W., Bao, Y., Yao, K., & Wu, B. (2026). Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis. AME Medical Journal, 11, 15-15. https://doi.org/10.21037/amj-2026-0041

Vancouver

Yan M, Chen Y, Li W, Bao Y, Yao K, Wu B. Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis. AME Medical Journal. 2026;11:15-15. doi:10.21037/amj-2026-0041

BibTeX
@article{Yan2026,
  author = {Yan, Mengxia and Chen, Ying and Li, Wen and Bao, Yun and Yao, Kaijie and Wu, Bin},
  title = {Comparative efficacy and safety of picankibart versus guselkumab and tildrakizumab for moderate-to-severe plaque psoriasis: a systematic review and individual participant data-anchored population-adjusted network meta-analysis},
  journal = {AME Medical Journal},
  year = {2026},
  volume = {11},
  pages = {15--15},
  doi = {10.21037/amj-2026-0041}
}
Kostenlos starten →